Cedars-Sinai Names Clinical Affairs EVP and Chief Medical Officer

Cedars-Sinai has named Ravi Thadhani, MD, MPH, executive vice president of Clinical Affairs and chief medical officer for Cedars-Sinai Medical Center and Cedars-Sinai Health System, effective Oct. 15.

A distinguished leader in academic medicine and an innovative physician scientist, educator and clinician, Thadhani will oversee clinical quality and safety, medical affairs and medical practice standards of care for the health system, including Cedars-Sinai Medical Network, Cedars-Sinai Marina Hospital and affiliated hospitals.

Thadhani is an internationally recognized clinical and translational leader in nephrology and preeclampsia, a leading cause of maternal and perinatal morbidity and mortality. He has led a successful research lab with continuous federal funding for more than 25 years, with a focus on kidney disease and developing diagnostics and therapeutics for patients with preeclampsia.

Thadhani began his career at Massachusetts General Hospital and Harvard Medical School. He served as vice dean for Research and Education at Cedars-Sinai Medical Center from 2017 to 2019 and now succeeds Richard V. Riggs, MD, who is leaving Cedars-Sinai at the end of 2025 to pursue other professional opportunities.

"Dr. Thadhani brings a wealth of organizational expertise to our evolving health system as well as academic excellence and clinical insight, and we're thrilled to have him back home at Cedars-Sinai," said Peter L. Slavin, MD, president and CEO of Cedars-Sinai Medical Center and Cedars-Sinai Health System. "We look forward to his many contributions to medical innovation and world-class patient care as our health system evolves."

After arriving at Cedars-Sinai in 2017, Thadhani worked with colleagues on groundbreaking researchto predict which pregnant women are at risk for a severe form of preeclampsia and developed the nation's first-ever FDA-approved preeclampsia diagnostic test. He now plans to rejoin the Cedars-Sinai teaminvolved in this research.

After his two-year stint with Cedars-Sinai, he returned to Harvard as professor of medicine and served as chief academic officer and dean for faculty affairs at Mass General Brigham.

In 2022, Thadhani was named executive vice president for health affairs at Emory University as well as vice chair of the Emory Healthcare Board of Directors and executive director of Emory's Woodruff Health Sciences Center, which includes Emory's schools of medicine, public health and nursing. During his tenure, Thadhani led a significant fiscal turnaround of the healthcare system while improving care access, quality and safety measures and IT services. He did this while also catalyzing the academic mission of the health sciences schools, which achieved top-tier rankings in the country.

Thadhani is the author or co-author of more than 300 scientific manuscripts that have been published in top-tier academic journals, including The New England Journal of Medicine, The Lancetand the Journal of the American Medical Association. He has been inducted into several honor societies, including the American Society for Clinical Investigation, the Association of American Physicians, the American Epidemiological Society and the American Clinical and Climatological Association.

"I'm honored to return to Cedars-Sinai, a place that has meant a great deal to me professionally and personally," Thadhani said. "I'm eager to get back to work alongside a dedicated and talented team as we further shape the future of Cedars-Sinai Health System and healthcare overall."

Read more in Cedars-Sinai Discoveries Magazine: Scientific Dream Team Aims to Make Preeclampsia a Relic of the Past